Srpt notice: did sarepta therapeutics, inc. mislead investors about the safety of elevidys? contact bfa law if you lost money (nasdaq:srpt)

New york, june 18, 2025 (globe newswire) -- leading securities law firm bleichmar fonti & auld llp announces an investigation into sarepta therapeutics, inc. (nasdaq: srpt) for potential violations of the federal securities laws. if you invested in sarepta, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action.
SRPT Ratings Summary
SRPT Quant Ranking